PROVISION OF A THERAPEUTICALLY ACTIVE CELL PRODUCT
A therapeutically active cell product and an ex vivo method for preparing it from a tissue donation are provided. The method comprises an in vitro immuno- depletion of hematopoietic stem cells and cells of hematopoietic lineage. The therapeutically active cell product obtained by the method comprise...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English French |
Published |
08.03.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A therapeutically active cell product and an ex vivo method for preparing it from a tissue donation are provided. The method comprises an in vitro immuno- depletion of hematopoietic stem cells and cells of hematopoietic lineage. The therapeutically active cell product obtained by the method comprises a portion of non-hematopoietic stem cells comprising non-hematopoietic progenitor [stem] cells, multipotent stem cells and/or pluripotent stem cells. Further aspects include the cell product for therapeutic use, in particular for the treatment of autoimmune and/or neurological disease.
L'invention concerne un produit cellulaire thérapeutiquement actif et un procédé ex vivo de préparation de ce dernier à partir d'un don de tissu. Le procédé comprend une immuno-déplétion in vitro de cellules souches hématopoïétiques et de cellules de lignée hématopoïétique. Le produit cellulaire thérapeutiquement actif obtenu au moyen du procédé comprend une partie de cellules souches non hématopoïétiques comprenant des cellules [souches] progénitrices non hématopoïétiques, des cellules souches multipotentes et/ou des cellules souches pluripotentes. D'autres aspects comprennent le produit cellulaire à usage thérapeutique, en particulier pour le traitement d'une maladie auto-immune et/ou neurologique. |
---|---|
Bibliography: | Application Number: WO2017CH00080 |